Literature DB >> 1852133

A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis.

P de Beer1, A el Harith, L L Deng, S J Semiao-Santos, B Chantal, M van Grootheest.   

Abstract

A fatal disease epidemic affected the Bentiu area in southern Sudan and led to a mass migration of the Nuer tribe searching for treatment. The initially available information revealed a high mortality rate due to a possible occurrence of tuberculosis, malaria, enteric fever or visceral leishmaniasis (VL). Serological screening of 53 of the most severely affected patients in an enzyme-linked immunosorbent assay (ELISA) or an improved direct agglutination test (DAT) revealed positivity for VL. In 39 of those patients, diagnosis was confirmed by identification of Leishmania donovani amastigotes in lymph node or bone-marrow aspirates. In a total of 2714 patients observed, 1195 (44.0%) had clinical symptoms suggesting VL: DAT positive titers (1:3200-greater than or equal to 1:12800) were obtained in 654 (24.1%), of whom 325 were confirmed parasitologically. Forty-two VL cases died before or during treatment, giving a mortality rate of 6.4%. Among the intercurrent infections diagnosed in the VL population (654), respiratory involvements (31.7%) and malaria (10.7%) were most prevalent. With the exception of four (0.6%), all other VL patients (509) responded readily to sodium stibogluconate. The factors initiating the outbreak are discussed. Malnutrition and nomadic movements to potential VL endemic areas appeared to be the most important. HIV infection as a possible predisposition seemed remote considering the clinical and epidemiological similarity to VL occurring in East Africa, adequate humoral response in DAT, and immediate positive response to specific anti-Leishmania chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852133     DOI: 10.4269/ajtmh.1991.44.283

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities.

Authors:  M S Chowdhury; A el Harith; A al Massum; E al Karim; A al Rahman
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Modifications in a Reference Freeze-Dried Direct Agglutination Test to Improve Visceral Leishmaniasis Detection.

Authors:  Abdallah El Harith; Yousif Awad; Abdelhafeiz Mahamoud; Elfadil Abass; Durria Mansour; Claudia Moura de Melo; Rubens Riscala Madi; Saul J Semiao-Santos; Hussam Ali Osman
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

4.  BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype.

Authors:  Karen J Bryson; Owain R Millington; Thabang Mokgethi; H Adrienne McGachy; Frank Brombacher; James Alexander
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

5.  Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Emily R Adams; Pètra F Mens; Elizabeth Sentongo; Dawson B Mbulamberi; Masja Straetemans; Henk D F H Schallig; Francois Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

6.  Visceral leishmaniasis outbreak in South Sudan 2009-2012: epidemiological assessment and impact of a multisectoral response.

Authors:  Abdinasir Abubakar; José Antonio Ruiz-Postigo; Jane Pita; Mounir Lado; Riadh Ben-Ismail; Daniel Argaw; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

Review 7.  Identifying the research gap of zoonotic disease in displacement: a systematic review.

Authors:  Dorien Hanneke Braam; Freya Louise Jephcott; James Lionel Norman Wood
Journal:  Glob Health Res Policy       Date:  2021-07-16

8.  Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Ayman B Y M Nour; Pètra F Mens; Al-Badawi A Talha; Emily R Adams; Hashim B M Ahmed; Samira H Abdelrahman; Koert Ritmeijer; Bakri Y M Nour; Henk D F H Schallig
Journal:  BMC Public Health       Date:  2013-04-11       Impact factor: 3.295

9.  rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.

Authors:  Elfadil Abass; Nadine Bollig; Katharina Reinhard; Bärbel Camara; Durria Mansour; Alexander Visekruna; Michael Lohoff; Ulrich Steinhoff
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18

10.  Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.

Authors:  Rahul Shivahare; Preeti Vishwakarma; Naveen Parmar; Pawan Kumar Yadav; Wahajul Haq; Mrigank Srivastava; Suman Gupta; Susanta Kar
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.